FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development

 
• By Brenda Sandburg
  
PFDD decade
Director of US FDA's patient-focused drug development program talks about its accomplishments and future initiatives • Source: Shutterstock

More from Leadership

More from In Vivo